RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding RenovoRx, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 8 | +8 |
| Shares | 0 | 169.1K | +169.1K |
| Value | $0 | $1.02M | +$1.02M |
New holders (8)
Institutions that held RenovoRx, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | 60,863 | $368.0K | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 40,850 | $247.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 20,569 | $125.0K | 0.00% |
| Two Sigma Securities, LLC | 17,944 | $108.0K | 0.02% |
| Citadel Advisors LLC | 12,010 | $73.0K | 0.00% |
| Harbor Financial Services, LLC | 11,100 | $67.0K | 0.03% |
| Tower Research Capital LLC (TRC) | 5,712 | $35.0K | 0.00% |
| Bank of America Corp | 100 | $1.00K | 0.00% |
Sold out (0)
Institutions that held RenovoRx, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.